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org/licenses/by/4.0/).Abstract Background and aims: Current guidelines on prediabetes and diabetes (T2D) recom-
mend to regularly perform an oral glucose tolerance test (OGTT) on subjects at risk of T2D. How-
ever, it is not known why women tend to have relatively higher 2-h post-load plasma (2hPG)
glucose concentrations during OGTT than men. The aim of the present study is to investigate
if there are sex differences in fasting plasma glucose (FPG) and 2hPG concentrations in relation
to body size in apparently healthy non-diabetic subjects with normal glucose tolerance. We hy-
pothesized that sex differences in glucose tolerance are physiological and related to different
body surface area (BSA) in men and women.
Methods and results: A 2-h 75 g OGTT was performed on 2010 subjects aged 45e70 years. Their
BSA was calculated using the Mosteller formula. Men and women were separately divided into
five BSA levels. Within the normal 2hPG range, women had higher mean 2hPG concentrations
during the OGTT than men in all BSA levels estimated by sex-standardized BSA (p for
linearity < 0.001). BSA adjusted for age, waist circumference, leisure-time physical activity,
and smoking, showed an inverse association with 2hPG concentration in both sexes. Mean
FPG concentrations were higher in men than in women.
Conclusions: Body size has a negative inverse association with 2hPG concentration in an OGTT
even within a physiological plasma glucose range. This may cause underestimation of glucose
disorders in individuals with larger BSA and overestimation in individuals with smaller BSA
when using an OGTT.
ª 2021 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Ital-
ian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the
Department of Clinical Medicine and Surgery, Federico II University. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Yliopisto, Finland. Fax: þ358 02 9450 5040.
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Sex difference in an oral glucose tolerance test 2679Introduction
The global epidemic of obesity is expanding the number of
people at risk for type 2 diabetes (T2D), thus increasing the
need and use of accurate diagnostic tests [1]. The European
and US guidelines recommend to regularly perform an oral
glucose tolerance test (OGTT) to subjects at increased risk
of T2D [2,3]. This means that in the general population,
asymptomatic people with overweight or obesity and one
or more additional risk factors for diabetes (e.g. history of
gestational diabetes, first-degree family history of T2D)
should be screened with an OGTT or a combination of
HbA1c and fasting plasma glucose (FPG) [3].
Previous studies using OGTT have shown that impaired
fasting glucose (IFG) is more prevalent in men while
impaired glucose tolerance (IGT) is more prevalent in
women [4]. Of the anthropometric measures, body mass
index (BMI) seems to be a better predictor of T2D in men
whereas waist circumference (WC) in women [5]. The
reasons for these sex differences are not known. Men and
women differ by body composition, sex hormones and
multiple other factors that control the metabolic homeo-
stasis [4]. It has also been postulated that shorter body
height may explain the higher 2-h post-load plasma
glucose (2hPG) concentrations in women [6e10]. The de-
terminants of adult height and the association of height
and development of T2D and cardiovascular disease (CVD)
are just beginning to be understood [11]. When BMI or WC
is used as a surrogate measure of body adiposity in clinical
practice and in research settings, the effect of body height
is diminished or dismissed. Thus, BMI and WC are not
applicable nor optimal to measure body size. On the con-
trary, body surface area (BSA) takes into account both body
height and weight as absolute measures and also different
body dimensions between men and women. We have
previously reported that the smaller the BSA of a person is,
the higher is the 2hPG concentration in an OGTT when the
effect of central adiposity is adjusted for [12]. Moreover,
the inverse relationship of BSA and 2hPG was already
present in subjects with normal glucose tolerance indi-
cating a physiological response to the standardized glucose
load in the OGTT [12].
The aim of the present study is to investigate if there
are sex differences in FPG and 2hPG with relation to body
size in apparently healthy non-diabetic subjects. We hy-
pothesized that sex differences in glucose tolerance are
related to different BSA levels in men and women.
Methods
Study population
The study subjects were drawn from a population survey,
the Harmonica (Harjavalta Risk Monitoring for Cardiovas-
cular Disease) project, which was carried out in south-
western Finland in the rural towns of Harjavalta and
Kokemäki in 2005e2007. All home-dwelling inhabitants
aged 45e70 years (n Z 6013), were mailed an invitation to
participate in the project, a validated T2D risk assessmentform (The Finnish Diabetes Risk Score questionnaire, FIN-
DRISC, available at https://www.diabetes.fi/english [13]), a
cardiovascular risk factor survey, and a measuring tape for
WC measurement. The participation rate was 74% (4450/
6013).
In the risk factor survey, the participants were asked to
report the latest measure of their blood pressure (140/
90 mmHg regarded as a risk factor), their use of antihy-
pertensive medication, any history of gestational diabetes
or hypertension, self-measured waist circumference at the
level of the umbilicus (80 cm in women or 94 cm in men
regarded as a risk factor), and family history (parents/
siblings) of coronary heart disease, myocardial infarction
or stroke. A FINDRISC score 12 in Harjavalta or, for lo-
gistics reasons 15 in Kokemäki was also regarded as a
risk factor (FINDRISC score  12 indicates that approxi-
mately 1 in 6 and  15 that 1 in 3 will develop T2D within
10 years [13]). Of the 4450 respondents, 3072 (69.0%) had
at least one risk factor but no manifested CVD, diabetes or
chronic kidney disease. They were invited to further ex-
amination performed by a trained study nurse. Valid data
of OGTT was available in 2659 study persons.
Laboratory tests were performed after at least 12 h of
overnight fasting. OGTT was performed by measuring FPG
and 2hPG concentrations after ingestion of a glucose load
of 75 g of anhydrous glucose dissolved in water. Glucose
concentrations were measured from capillary whole blood
samples using the HemoCue Glucose 201þ system
(Ängerholm, Sweden). The results were converted from
capillary whole blood to capillary plasma glucose values by
the analyser. Glucose regulation was classified according to
the WHO 1999 criteria [14]. On the basis of OGTT, subjects
were classified into normal glucose tolerance if their FPG
were <6.1 mmol/l and 2hPG concentrations were
<8.9 mmol/l. For the present analysis, only subjects with
normal FPG and 2hPG values in OGTT (n Z 2010) were
included. Plasma total cholesterol, triglycerides and HDL
cholesterol were measured enzymatically (Olympus
AU604, Japan). LDL cholesterol was calculated by Fried-
wald’s formula [15].
Blood pressure was measured in a sitting position after
at least 5 min rest by a study nurse using a calibrated
mercury sphygmomanometer. The mean of two readings
taken at intervals of 2 min was used in the analyses. Body
weight, body height and WC were measured by a study
nurse. WC was measured at the level midway between
the lowest rib margin and the iliac crest. BMI was calcu-
lated as weight (kg) divided by the square of height (m2).
BSA was calculated using the Mosteller formula [weight
(kg) x height (cm)/3600]1/2 [16]. The relationship with
BMI and BSA in the present study population is shown in
Fig. 1.
Participants reported education years, leisure-time
physical activity (LTPA), smoking status and alcohol use
(Alcohol Use Disorder Identification Test, AUDIT [17]) by
completing self-administrated questionnaires at the clinic.
LTPA was classified as high, moderate or low if  30 min
physical activity at a time was performed six or more, four
to five, three or less times a week, respectively.
Figure 1 The relationship between body surface area and body mass
index levels in men and women. The grey areas represent 95% confi-
dence intervals.
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The ethics committee of Satakunta hospital district
reviewed and approved the study protocol and consent
forms. All participants provided written informed consent
for the project and subsequent medical research.Statistical analysis
Data were expressed as the mean and standard deviation
(SD), or counts and percentages. Men and women were
separately divided into five sex specific BSA level cate-
gories corresponding 12.5, 25, 25, 25, and 12.5% of the total
distribution. Statistical significances for the hypothesis of
linearity across gender specific level of body surface area
(BSA) were evaluated by using the CochraneArmitage test
for trend and analysis of variance with an appropriate
contrast (orthogonal). The main and interactive effects of
gender and BSA levels were analyzed by entering gender
and BSA and their interaction as independent variables
into the models. Age, waist circumference, leisure time
physical activity, and smoking were introduced into the
models as covariates. Linear regression analyses were used
to identify the BSA levels of the glucose tolerance test
using crude and adjusted standardized regression co-
efficients Beta (b). The Beta value is a measure of how
strongly each predictor variable influences the criterion
(dependent) variable. A possible nonlinear relationship
between glucose tolerance test and the sex-specific BSA
were assessed by using 4-knot-restricted cubic spline
regression. Knot locations were based on Harrell’s rec-
ommended percentiles [18]. The bootstrap method was
used when the theoretical distribution of the test statistics
was unknown or in the case of violation of the assump-
tions (e.g. non-normality). The normality of variables wasevaluated graphically and using the ShapiroeWilk W test.
Stata 16.1 (StataCorp LP; College Station, Texas, USA) sta-
tistical package was used for the analysis.Results
The study included 2010 participants (841 men, 1169
women) who had normal glucose tolerance. Their mean
age was 57  7 years (men) and 58  7 years (women),
58% were women.
Table 1 shows the characteristics of the subjects ac-
cording to sex and the five BSA categories. In both men and
women, increasing BSA level was associated with
decreasing HDL cholesterol and increasing triglyceride
concentrations as well as higher diastolic BP levels and
usage of antihypertensive medication. Subjects with larger
BSA were less engaged in LTPA than relatively smaller
subjects (p for linearity < 0.001). Male participants with
larger BSAwere younger (p for linearity < 0.001) and more
educated (p for linearity 0.002) than man with smaller
BSA. In women only, LDL cholesterol concentration
increased with increasing BSA level (p for linearity 0.031).
Although all anthropometric measures rose linearly
according to BSA level categories in both sexes (Table 1), at
all BMI levels women had lower BSA than men.
In linear regression analysis, BSA showed a negative
linear relationship with 2hPG in both men and women
independently of age, WC, LTPA, and smoking. The line-
arity between BSA and FPG was positive in women but
disappeared when adjusted for confounding variables
(Table 2).
Fig. 2 shows the mean FPG concentrations in relation to
sex and BSA levels. The difference between men and
women was statistically significant (p Z 0.038) and was
located in the smallest BSA level being 0.18 mmol/l (95%
CI: 0.06 to 0.31), p Z 0.004. There was no linearity be-
tween the FPG concentrations and BSA levels (p Z 0.61),
nor an interaction (p Z 0.11). The continuous BSA spline
curve shows that men with BSA below average had higher
FPG concentrations compared to women, but no gender
difference was observed with larger BSA (Fig. 2).
Women had consistently higher mean 2hPG concen-
trations than men at all BSA levels (p < 0.001). In both
sexes, 2hPG concentrations showed a negative linear
relationship with BSA levels (p for linearity <0.001) but no
interaction (p Z 0.36). The sex difference in 2hPG con-
centrations was highest at the largest BSA level, being
0.76 mmol/l (95% CI: 1.15 to 0.37), p < 0.001 (Fig. 3).Discussion
This study demonstrates that within the glucose ranges
considered normal, apparently healthy women have
higher mean postechallenge glucose concentrations in the
OGTT than men in all body size categories estimated by
sex-specific BSA. The higher the BSA adjusted for factors
related to increased risk for diabetes, the lower is the
postechallenge concentration in both sexes. BSA takes into






















Age, years, mean (SD) 59.0 (6.8) 57.6 (7.0) 58.3 (6.6) 56.3 (6.7) 55.9 (6.4) <0.001
Education years, mean (SD) 9.6 (2.2) 10.2 (2.5) 9.8 (2.3) 10.9 (2.8) 10.2 (2.3) 0.002
Height, cm, mean (SD) 170 (5) 174 (5) 177 (6) 180 (5) 184 (6) <0.001
Weigh, kg, mean (SD) 70 (5) 80 (3) 87 (4) 95 (4) 112 (10) <0.001
Body mass index, kg/m2, mean (SD) 24.4 (2.3) 26.3 (2.3) 27.8 (2.8) 29.6 (2.8) 33.2 (4.1) <0.001
Waist circumference, cm, mean (SD) 88.2 (6.8) 94.3 (5.9) 99.4 (6.6) 104.2 (6.5) 114.6 (9.9) <0.001
Fasting plasma glucose, mmol/l, mean (SD) 5.28 (0.53) 5.22 (0.47) 5.30 (0.48) 5.36 (0.48) 5.28 (0.39) 0.077
2-h post-load plasma glucose, mmol/l, mean (SD) 7.03 (1.46) 6.95 (1.68) 6.83 (1.83) 6.78 (1.70) 6.75 (1.76) 0.12
Total cholesterol, mmol/l, mean (SD) 5.36 (0.93) 5.40 (0.95) 5.24 (0.88) 5.34 (1.03) 5.37 (0.99) 0.78
HDL cholesterol, mmol/l, mean (SD) 1.56 (0.39) 1.52 (0.47) 1.40 (0.36) 1.39 (0.47) 1.21 (0.30) <0.001
LDL cholesterol, mmol/l, mean (SD) 3.28 (0.80) 3.31 (0.86) 3.25 (0.85) 3.29 (0.94) 3.39 (0.88) 0.52
Triglycerides, mmol/l, mean (SD) 1.19 (0.64) 1.33 (0.67) 1.40 (0.74) 1.56 (0.76) 1.72 (0.73) <0.001
Blood Pressure, mmHg, mean (SD)
Systolic 140 (20) 140 (16) 141 (17) 139 (18) 143 (19) 0.34
Diastolic 83 (10) 85 (10) 87 (10) 87 (9) 91 (10) <0.001
Current smoker, n (%) 28 (27) 37 (18) 45 (22) 40 (19) 14 (13) 0.075
AUDIT score, mean (SD) 6.8 (5.6) 6.6 (5.5) 6.8 (5.2) 6.6 (5.2) 7.0 (5.1) 0.82
Leisure time physical activity, n (%) <0.001
Low 12 (12) 34 (17) 47 (23) 49 (24) 36 (35)
Moderate 55 (55) 111 (54) 96 (47) 98 (48) 48 (47)
High 33 (33) 59 (29) 63 (31) 56 (28) 19 (18)
Current medication, n (%)
Statins 7 (7) 22 (10) 34 (16) 25 (12) 10 (10) 0.43
Antihypertensives 21 (20) 48 (23) 71 (34) 68 (32) 46 (44) <0.001






















Age, years, mean (SD) 58.2 (7.6) 58.5 (7.1) 57.8 (6.9) 57.7 (6.8) 57.3 (7.3) 0.11
Education years, mean (SD) 10.9 (2.8) 10.7 (2.9) 10.8 (2.9) 10.6 (2.8) 11.1 (2.9) 0.83
Height, cm, mean (SD) 158 (5) 161 (5) 163 (5) 164 (6) 167 (6) <0.001
Weight, kg, mean (SD) 57 (4) 65 (3) 73 (3) 83 (5) 101 (11) <0.001
Body mass index, kg/m2, mean (SD) 22.9 (2.4) 25.3 (2.3) 27.4 (2.5) 30.8 (3.6) 36.6 (5.5) <0.001
Waist circumference, cm, mean (SD) 76 (6) 82 (6) 89 (6) 97 (8) 109 (10) <0.001
Fasting plasma glucose, mmol/l, mean (SD) 5.04 (0.48) 5.16 (0.51) 5.17 (0.49) 5.28 (0.43) 5.29 (0.44) <0.001
2-h post-load plasma glucose, mmol/l, mean (SD) 6.89 (1.44) 6.85 (1.51) 6.97 (1.43) 6.90 (1.55) 7.30 (1.72) 0.034
Total cholesterol, mmol/l, mean (SD) 5.46 (0.91) 5.57 (0.97) 5.55 (0.93) 5.55 (0.94) 5.54 (0.90) 0.63
HDL cholesterol, mmol/l, mean (SD) 1.84 (0.46) 1.82 (0.41) 1.72 (0.42) 1.61 (0.40) 1.48 (0.34) <0.001
LDL cholesterol, mmol/l, mean (SD) 3.15 (0.79) 3.26 (0.92) 3.26 (0.85) 3.34 (0.89) 3.34 (0.87) 0.031
Triglycerides, mmol/l, mean (SD) 1.09 (0.65) 1.12 (0.63) 1.28 (0.65) 1.35 (0.59) 1.64 (0.81) <0.001
Blood Pressure, mmHg, mean (SD)
Systolic 136 (19) 139 (18) 136 (17) 138 (18) 141 (15) 0.12
Diastolic 80 (10) 81 (9) 82 (9) 84 (9) 86 (9) <0.001
Current smoker, n (%) 24 (17) 40 (14) 35 (12) 33 (11) 18 (12) 0.16
AUDIT score, mean (SD) 2.8 (3.2) 2.7 (2.8) 2.9 (3.1) 2.9 (2.8) 2.6 (3.4) 0.88
Leisure time physical activity, n (%) <0.001
Low 16 (11) 23 (8) 32 (11) 46 (16) 34 (24)
Moderate 61 (42) 149 (52) 148 (52) 143 (51) 80 (56)
High 67 (47) 115 (40) 104 (37) 94 (33) 28 (20)
Current medication, n (%)
Statins 9 (6) 27 (9) 21 (7) 35 (12) 16 (11) 0.071
Antihypertensives 24 (16) 65 (22) 63 (22) 97 (33) 77 (52) <0.001
Abbreviations: BSA, body surface area; HDL high-density lipoprotein; LDL, low-density lipoprotein; AUDIT, Alcohol Use Disorder Identification
Test.
To convert values for glucose to milligrams per decilitre, multiply by 18.016.
Sex difference in an oral glucose tolerance test 2681account the difference in body size between men and
women as opposed to BMI.
The relationship between body size, sex and glucose ho-
meostasis is a complex entity. An increasing number ofstudies indicate, that sex plays an important part in the
metabolic regulation and susceptibility to diabetes [19]. The
present study of apparently healthy subjects showed, that
men have slightly higher mean FPG than women without
Table 2 Regression models for the relationship between body surface area (BSA) levels and diagnostic variables (FPG and 2hPG) in men and
women.































































P for linearity p < 0.001 0.15 0.22 0.034 <0.001 <0.001
Men BSA level

















































P for linearity 0.082 0.70 0.59 0.12 <0.001 <0.001
Model 1: crude.
Model 2: adjusted for age and waist circumference.
Model 3: adjusted for age, waist circumference, leisure time physical activity, and smoking.
a The values of the standardized regression coefficients (Beta).
2682 S. Palmu et al.interaction with BSA. This might be related to the funda-
mental sexdifferences in the utilizationof carbohydrates and
lipids as fuel sources [4]. At rest and during the post-
absorptive state the female body favors energy storage [5]
which might explain why women show lower fasting
endogenous glucose production [20],whereas themale body
aims at mobilizing energy stores through plasma FFA oxida-
tion [5]. Furthermore, the larger the person, the larger the
liver [21] and skeletal muscle mass [22] e thus, probably
larger glycogen storage to be mobilized.
Our previous study reported that the OGTT identifies
more T2D and IGT in relatively smaller sized individuals
[12]. In the present study, we focused on the normogly-
cemic range and analyzed men and women separately. BSA
showed a negative relationship with 2hPG in both sexes,
and women had higher mean 2hPG concentrations than
men when the effects of age, abdominal obesity, LTPA, and
smoking were taken into account. This information is
indicative of a physiological phenomenon related to body
size. The gut absorption rate of glucose has been found to
be slower in women compared with men and to have a
negative correlation with height, but not with BMI, in both
sexes [20]. Many previous studies have postulated that
shorter body height may explain the higher 2hPG con-
centrations in women [6e10].
Adult height is determined by genetic and environ-
mental factors [23]. Women have on average more adipose
tissue and less skeletal muscle mass than men, andwomen have an increased propensity to gain fat [4]. The
relationship between weight and height is not equal be-
tween men and women, and BMI is not independent of
height, but the correlation is inverse in most populations
[24]. With the same BMI, women are likely to have a
greater percentage of body fat than men [25]. In epide-
miological studies height is rarely taken into account. The
importance of proper adjustment for confounding vari-
ables such as age, sex and anthropometric measures has
recently been addressed also in the 2018 Cochrane review
“Development of type 2 diabetes mellitus in people with
intermediate hyperglycaemia” [26].
Tura et al. [27] and Kautzky-Willer et al. [28] have
assessed metabolism in subjects with normal glucose
tolerance with more sophisticated methods than those
used in our study. The results showed that females had
lower fasting but higher post-load glucose values even
after correction for age and BMI [27,28]. Taken together, all
these studies imply that sex and body size are important
factors to be considered when assessing glucose meta-
bolism with an OGTT.
The main limitation of this study is its cross-sectional
setting which prevents to assess causalities. HbA1c was not
measured in the present study and relationship with
HbA1c, and body size would be a subject of future research.
Although the lifestyle-related factors were assessed with
self-administrated questionnaires and dietary habits were
not gathered, anthropologic measurements were made by
Figure 2 Mean fasting plasma glucose (FPG) by sex-specific body surface area level and sex. Adjusted for age, waist circumference, leisure time
physical activity, and smoking. Error bars are for 95% confidence intervals. The difference of continuous FPG between men and women were derived
from a 4-knot restricted cubic splines regression model. The grey area represents a 95% confidence interval.
Sex difference in an oral glucose tolerance test 2683trained medical staff. Another strength of our study is that
the study population represents a healthy population at
increased risk of diabetes or CVD, to whom OGTT is rec-
ommended to be performed, and whose future risk ofFigure 3 Mean 2-h plasma glucose (2hPG) by gender specific body surface
physical activity, and smoking. Error bars are for 95% confidence intervals
derived from a 4-knot restricted cubic splines regression model. The grey adiabetes is possible to be reduced through interventions.
However, our results may not be generalized to persons
without any cardiovascular risk factors or persons with
glucose disorders.area level and sex. Adjusted for age, waist circumference, leisure time
. The difference of continuous 2hPG between men and women were
rea represents a 95% confidence interval.
2684 S. Palmu et al.In conclusion, BSA has an inverse relationship with 2hPG
concentration in both sexes, and women have higher 2hPG
concentrations than men in an OGTT even within the
physiological glucose range. This may cause underestima-
tion of glucose disorders with larger BSA and over-
estimation with smaller BSA when using an OGTT. Albeit
our results apply only to people with normal glucose
tolerance, we challenge the use of an OGTT as an appro-
priate diagnostic method to detect glucose disorders.
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